Schnitzer TJ, et al. Efficacy and Safety of Subcutaneous Tanezumab for the Treatment of Osteoarthritis of the Hip or Knee. ACR 2018, abstract L20.
Jaarverslag Reumafonds: 10 miljoen naar reumaonderzoek
aug 2017 | Arthritis psoriatica, Artrose, Fibromyalgie, JIA, Jicht, Osteoporose, RA, Sclerodermie, Sjögren, SLE, Spondyloartritis